Our project investigates the biology of cancer, particularly breast cancer. Our team looks at developing targeted therapies that could be more efficient than existing therapies to treat this form of cancer.
Frank Hoover
Frank has a background as a researcher and group leader in Academia and the Biotechnology Industry as well as executive positions in start-up companies. For more than 20 years he was driven by hypothesis-related and innovative research towards the molecular mechanisms that control the central nervous system communication, development and disease. Now he applies this scientific and business experience to assist research-based projects and startup companies.
At VIS he looks to grow good innovative ideas from the owner institutions. He advises, looks for financing opportunities, develops Intellectual Property portfolios and commercialization strategies. He enjoys working closely with the researchers to grow and valorize their Eureka moments.
Outside of the office, Frank also likes watching and helping things grow using bio-sustainable methods and is a beekeeper.
Education: Dr. Philos. in Biological Chemistry, University of Michigan.
Prosjektleder for:
Using modern biology this project has uncovered a platform to make complex natural products to be exploited for unmet medical needs.
Therapies against cancer are challenging due to the heterogeneity of cancer cells. This project represents a strong collaboration between two disciplines coming together to develop novel molecules for cancer treatment.
Understanding and developing treatments for Central Nervous Disease (CNS) has been hampered by the complexity and the uniqueness of the CNS. This project aims to identify relevant pathways and molecules that can be targeted so that better treatments can evolve.